Renal Dialysis Equipment Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

Renal Dialysis Equipment Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

The global renal dialysis equipment market is expected to register a CAGR of 9.8% over the forecast period.

As per Johns Hopkins University, some people with COVID-19 showed signs of kidney damage, and even those who had no underlying kidney problems before were infected with the coronavirus. Moreover, about 30% of patients hospitalized with COVID-19 in New York and China developed moderate or severe kidney injury. In patients with COVID-19, signs of kidney problems include abnormal blood work and high levels of protein in the urine, which may lead to kidney damage in some cases and require dialysis.

As per the National Kidney Foundation Inc., in 2020, people who are on dialysis treatment may be at higher risk for severe disease from COVID-19. For severe cases, patient recovery may take six weeks or more. About 1% of infected patients will die from the disease.

Some of the factors driving the market growth include primarily attributed to the rise in the number of end-stage renal disease patients (ESRD), growing demand for peritoneal dialysis, rise in cost-effective and accurate portable dialysis apparatus, and advanced technologies.

The renal dialysis equipment market is expected to show good growth due to the expanding number of dialysis centers, growth in R&D expenditure for the development of new dialysis products, and increasing end-stage renal diseases. In January 2019, Baxter International Inc. received the US FDA approval for its clinical trial on-demand peritoneal dialysis solution generation system. The new system offers a good platform for patients to perform dialysis at home.

Globally, there has been an increase in the incidence of renal diseases, such as kidney diseases, in developed and developing countries. Dialysis is referred to patients with end-stage renal disorder (ESRD) or chronic kidney diseases.

According to a 2018 study conducted by the University of California San Francisco, an estimated 2 million people worldwide suffered from end-stage renal disorders (ESRD).

According to a research study by Jennifer A Hirst et al., published in the British Journal of General Practice 2020, about 44.0% of people in the United Kingdom with chronic kidney disease (CKD) were undiagnosed without screening, and the prevalence of chronic kidney disease (CKD) stages 1-5 was 18.2% in patients aged above 60 years. Thus, the increasing burden of disease is expected to boost the market growth over the forecast period. However, factors, such as complications and risks associated with dialysis and reimbursement issues, may impede the market growth over the forecast period.

Key Market TrendsHemodialysis (HD) Equipment is Expected to Hold Significant Market Share During the Forecast Period

Globally, hemodialysis equipment adoption is steadily increasing due to the increasing prevalence of kidney failure patients. It is used to filter wastes and water from the blood. Thus, market players are found focusing on the developments of the new hemodialysis equipment that help in the growth of the overall market.

COVID‐19 is a very high transmission infectious disease with a variable prognosis in the general population. Patients in hemodialysis therapy are vulnerable to developing an infectious disease. Moreover, COVID‐19 is a very high transmission disease, and risk factors such as age, hypertension, diabetes, cancer, and chronic respiratory and cardiovascular disease are associated with the worst prognosis. For instance, according to a research article by Claudia Benedetti et al., published in Frontiers in Medicine Journal 2020, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients for a more severe disease course. COVID-19 infects the kidneys and may induce acute kidney injury.

Furthermore, a research article by Meritxell Ibernon et al., published in Hemodialysis International Journal 2020, found that COVID-19 has shown a high incidence and mortality rate in hemodialysis patients. Thus, early preventive measures against COVID-19 could decrease the risk of spreading disease in vulnerable patients.

Some of the factors which are driving the segment growth include the rising prevalence of kidney diseases such as end-stage renal disease (ESRD), along with increasing innovative product launches in the market by market players.

According to the Australian Institute of Health and Welfare National Mortality Database, in 2018, chronic kidney disease contributed to about 11% of all deaths (around 16,800 deaths) in Australia. Chronic kidney disease was the underlying cause of death in around 3,600 deaths (21% of CKD deaths).

Furthermore, technological advancements in healthcare are leading to the development of hemodialysis machines with improved ergonomics. For instance, in 2019, Fresenius Medical Care launched 4008A, an advanced hemodialysis machine in the Indian market. The newly launched machine is equipped with new blood filtration technology. Thus, the above-mentioned mentioned factors are expected to drive segment growth over the forecast period.

North America is Expected to Dominate the Renal Dialysis Equipment Market Over the Forecast Period

The factors driving the market growth in North American include the massive adoption of new technologies in the kidney dialysis division. There is also a boom in public healthcare expenditure and an increase in awareness programs about the availability of advanced treatments.

The novel coronavirus disease 2019 (COVID-19) has a high mortality rate among older adults and individuals suffering from chronic diseases, such as chronic kidney diseases (CKD). As per the Centers for Disease Control and Prevention (CDC) 2019, in the United States, about 15% of adults suffer from chronic kidney diseases (CKD).

Furthermore, in the United States, patients with pre-existing chronic kidney disease (CKD) were considered to be largely susceptible to COVID-19. For instance, a research article by Jennifer E Flythe et al., published in the American Journal of Kidney Diseases 2020, stated that high mortality can be observed in patients with underlying kidney disease and severe COVID-19.

According to a research article by Pietro Ravani et al., published in JAMA Journal 2020, the study results found that the incidence rate of stage IV chronic kidney disease increased with advancing age. For those aged 75 years and older, the risk of death was much higher than the risk of kidney failure. The high burden of chronic kidney disease is expected to boost the market, increasing the demand for renal dialysis in the coming years.

Some of the market players involved in the US market include DaVita, Baxter International, Medtronic, and U.S. Renal Care. These players adopted various strategies, such as collaborations, mergers, acquisitions, and product innovations, to maintain their market position. For instance, in March 2017, the US renal care announced the expansion of its dialysis clinic in Dallas. This expansion allowed the company to broaden its business operations and increase its customer base.

Thus, the above-mentioned factors are expected to drive market growth over the forecast period.

Competitive Landscape

The renal dialysis equipment market is fragmented and competitive, with several market players. Some of the market players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions, to increase their footprints in this market. Some of the market players include Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International Inc., Nikkiso Co. Ltd, and Nipro Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Fresenius Kabi AG
Baxter International, Inc.
Nipro Corporation
B. Braun Melsungen AG
Nikkiso Co. Ltd
Asahi Kasei Corporation
Medtronic PLC
Rockwell Medical
Teleflex Incorporated
Allmed Medical Care Holdings Limited
Medivators Inc
Toray Medical Co. Ltd
Hemoclean Co. Ltd
Medtronic PLC
Quanta
Outset Medical Inc.

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.